Board of Directors

Ton Logtenberg, Ph.D (CEO, Executive Director)

Ton Logtenberg has served as our Chief Executive Officer and as board member since co-founding our Company in June 2003.

Mark Iwicki (Chairman, Non-Executive Director)

Mark Iwicki has been a member of the Board since June 2015.

Gregory Perry (Non-Executive Director)

Gregory Perry has been a member of our board since May 2016. Mr. Perry has been the chief financial and administrative officer of Novelion Therapeutics, a biopharmaceutical company, since July 2015. Prior to joining Novelion Therapeutics, Mr. Perry served as chief financial and business officer of Eleven Biotherapeutics, Inc., a biopharmaceutical company, from December 2013 […]

Lionel Carnot (Non-Executive Director)

Lionel Carnot, MS, MBA, has been a member of the Board since January 2010.

Wolf Berthold, Ph.D. (Non-Executive Director)

Wolf Berthold, Ph.D., has been a member of the Board since 2010. Wolf is the president of Berthold BioPharm Consulting GmbH.

John de Koning, Ph.D. (Non-Executive Director)

John de Koning, Ph.D., has been a member of Merus´ Board since January 2010. John is a partner at Life Sciences Partners (LSP).

Anand Mehra, M.D. (Non-Executive Director)

Anand Mehra, M.D. has been a member of the board since August 2015. Dr. Mehra has been with Sofinnova Ventures since 2007, most recently holding the position of a general partner where he focuses on working with entrepreneurs to build drug development companies. He has led the firm’s investments in Vicept Therapeutics (acquired by Allergan), […]

Anne Noordzij, LL.M. (Secretary)

Anne Noordzij holds a law degree and has been Head of Legal Europe and secretary to the board since November 2015. Before joining Merus, Anne was a lawyer at one of the top Dutch law firms in the Netherlands, NautaDutilh N.V., where she advised in a variety of transactions, with a focus on the Life […]